Jacobs has been chosen to offer engineering services for Mark Cuban Cost Plus Drug Company, PBC’s pharmaceutical facility in Dallas, Texas, the US.
The facility will offer low-cost versions of expensive generic drugs.
Go deeper with GlobalData
The Mark Cuban Cost Plus Drug Company, PBC awarded contract to Jacobs to finish facility design, right from concept through construction assistance.
Value of the contract has not been disclosed.
The 22,000ft2 sterile fill-finish facility will support formulation, filling and packaging of sterile medicines.
Jacobs People & Places Solutions executive vice president Ken Gilmartin said: “We look forward to helping Mark Cuban Cost Plus Drug Company, PBC deliver on its aim to make essential life-enhancing drugs available to more people.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“The facility’s innovative design will allow for the production of small product batches considered in short supply by the FDA and those intended for treatment of rare diseases that typically affect a smaller population, known as orphan drugs”
Jacobs claimed that the identification of mechanical enhancements and use of advancements in equipment have been important to cutting down construction and capital costs.
The firm, supporting the delivery programme of just over two years, completed concept and detailed design within 12 months, as against the regular timeframe of 20 to 24 months for sterile fill-facilities.
Construction of the facility is expected to complete in 2022.
———————————————————————————————————————
Image: The flexible fill-finish facility will provide low-cost versions of high-cost generic drugs. Credit: Jacobs.
